NFKB1 and systemic lupus erythematosus: Previous investigations have observed upregulated IκKα expression and enhanced NF-κB activation in lupus nephritis patients (49), while NF-κB kinase activity inhibition increased survival rates and reduced renal pathological changes in NZB/W F1 mice, another spontaneous SLE model (50).